Bengaluru: German defence electronics leader HENSOLDT has reinforced its strategic commitment to India, signing two major ...

This acquisition marks a significant step in Jubilant Biosys' global strategy, providing a foothold in Europe's expanding ...

The central bank has been shoring up its gold reserves, cushioning the rupee against currency volatility and fuelling ...

Jubilant Biosys Innovative Research Services Pte. Limited, Singapore (JBIRSPL), a subsidiary of Jubilant Biosys Limited, a wholly owned subsidiary of Jubilant Pharmova Limited, has executed the ...

A lower-than-expected CPI inflation print in January 2025 is likely to give RBI MPC further policy room for another 25 bps ...

Real estate was a dominant contributor with 8 developers & 1 REIT collectively raising Rs 22,320 Cr - a 16% overall share.

The rupee's sharp decline is likely to drive a further increase in non-resident Indian (NRI) remittances, particularly from ...

The S&P 500 and Dow industrials fell after CPI rose 3% in January from a year earlier. The Nasdaq Composite edged higher. U.S. investors are looking abroad in pursuit of higher stock-market returns.

China’s Influence, Leverage, and Regional Balancing in Asia China’s increasing engagement in multilateral institutions, ...

BSE Sensex closes lower for sixth day due to foreign sell-off, tariff concerns, and rise in demand for treasury bonds.

Trump's tariffs will not only impact sponsors, but higher costs will ripple down the clinical trial supply chain in the US.

The economic case for sustainability is clear and a green transition has capital market backing for good reason. A policy ...